(PharmaNewsWire.Com, September 09, 2021 ) According to a new market research report "Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023", published by MarketsandMarkets™, the market is expected to reach USD 2.21 Billion by 2023 from an estimated USD 1.46 Billion in 2018, at a CAGR of 8.7% during the forecast period.
Browse in-depth TOC on "Oncology Nutrition Market"
1. To define, describe, segment, and forecast the oncology nutrition market for different types of cancer
2. To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, and industry-specific opportunities)
3. To forecast the size of the oncology nutrition market, in four main regions —North America (along with countries), Europe (along with countries), Asia Pacific, and the Rest of the World
4. To identify and profile key players in the global oncology nutrition market and comprehensively analyze their core competencies and market shares
5. To track and analyze competitive developments such as mergers and acquisitions; new product launches; expansions; collaborations and agreements; and R&D activities of the leading players in the global oncology nutrition market
Factors such as the shift from parenteral to enteral nutrition along with the increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions are driving the growth of the Oncology Nutrition Market. Furthermore, the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of excipients. However, the complications associated with tube feeding and limited reimbursements represent a significant challenge to the market growth.
By cancer type, the head and neck cancers segment accounted for the largest share of the market
On the basis of type of cancer, the head and neck cancers segment accounted for the largest share of the Oncology Nutrition Market, in 2017. This can be attributed to the use of tube feeding formulas for patients with head and neck cancers as conditions such as severe mucositis, xerostomia, dyspepsia, and nausea & vomiting in these patients limits nutritional intake.
North America accounted for the largest share of the Oncology Nutrition Market in 2017, followed by Europe. This regional segment shows significant market growth owing to the increasing prevalence of chronic diseases and disorders, coupled with rapidly growing aging population, which shows greater susceptibility to chronic and acute disorders than other population segments. In addition, long-term care facilities such as homecare & hospices, nursing homes, and assisted living facilities have emerged as efficient alternatives to hospitals. Furthermore, owing to cost-cutting pressures in hospitals, the healthcare system has seen a shift from extended hospital treatment to treatment at home, which is expected to propel the demand for such feeding formulas.
The prominent players in the Oncology Nutrition Market are Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France), Fresenius Kabi AG (Germany), and B. Braun Melsungen AG (Germany).
Browse Adjacent Markets @ Pharmaceutical Market Research Reports & Consulting
Enteral Feeding Devices Market By Type (Feeding Pump, Feeding Tube, Giving Set, Syringes), Age Group (Adult, Pediatric), Application (Oncology, Diabetes, Hypermetabolism), End User (Hospital, Home Care), COVID-19 Impact - Global Forecast To 2025
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: